{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:39:32Z","timestamp":1778960372629,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","award":["NIHR-CS-011-001"],"award-info":[{"award-number":["NIHR-CS-011-001"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.psychres.2017.05.009","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T09:04:53Z","timestamp":1494493493000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis"],"prefix":"10.1016","volume":"255","author":[{"given":"Tabea","family":"Schoeler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Petros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Di Forti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Klamerus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Foglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagnik","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2017.05.009_bib1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.201100118","article-title":"Validity of hospital admission as an outcome measure of services for first-episode psychosis","author":"Addington","year":"2012","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2017.05.009_bib2","first-page":"1","article-title":"Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study","volume":"1","author":"Barbeito","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","article-title":"Modulation of mediotemporal and ventrostriatal function in humans by {Delta} 9-tetrahydrocannabinol: a neural basis for the effects of cannabis sativa on learning and psychosis","volume":"4","author":"Bhattacharyya","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/mp.2011.187","article-title":"Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of [delta]\u22129-tetrahydrocannabinol on midbrain and striatal function","volume":"12","author":"Bhattacharyya","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archgenpsychiatry.2011.161","article-title":"Induction of psychosis by\u03b49-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing","volume":"1","author":"Bhattacharyya","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/npp.2014.258","article-title":"Cannabinoid modulation of functional connectivity within regions processing attentional salience","volume":"6","author":"Bhattacharyya","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2017.05.009_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euroneuro.2014.11.018","article-title":"Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis","volume":"25","author":"Bhattacharyya","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2017.05.009_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.psychres.2017.05.009_bib9","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1017\/S0033291714000920","article-title":"Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control","volume":"44","author":"Bhattacharyya","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2017.05.009_bib10","first-page":"53","article-title":"Early intervention in psychosis. The critical period hypothesis","volume":"Supplement 33","author":"Birchwood","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","article-title":"Dose-related neurocognitive effects of marijuana use","volume":"9","author":"Bolla","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2017.05.009_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jpsychires.2012.05.001","article-title":"Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study","volume":"8","author":"Caseiro","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0447.2002.02437.x","article-title":"Medication adherence of individuals with a first episode of psychosis","volume":"4","author":"Coldham","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.05.009_bib14","article-title":"Substance use, medication adherence and outcome one year following a first episode of psychosis","author":"Colizzi","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib15","unstructured":"Core Team, R., 2015. \"R: A Language and Environment for Statistical Computing.\" Retrieved 09. September 2015, 2015, from \u3008https:\/\/cran.r-project.org\/doc\/manuals\/fullrefman.pdf\u3009."},{"key":"10.1016\/j.psychres.2017.05.009_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","article-title":"Cognitive and subjective dose-response effects of acute oral \u03949-tetrahydrocannabinol (THC) in infrequent cannabis users","volume":"1","author":"Curran","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2017.05.009_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"6","author":"D\u2019Souza","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-2007-992141","article-title":"Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up","volume":"06","author":"De Haan","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.biopsych.2012.06.020","article-title":"Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users","volume":"10","author":"Di Forti","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib20","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"6","author":"Di Forti","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.05.009_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"3","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"3","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/schbul\/sbv015","article-title":"Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention","volume":"3","author":"Drake","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.05.009_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2012.07.023","article-title":"Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis","volume":"1","author":"Faridi","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib25","doi-asserted-by":"crossref","unstructured":"Foglia, E., Schoeler, T., Klamerus, E., Morgan, K., Bhattacharyya, S., in preparation. Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28179039,\u00a0http:\/\/dx.doi.org\/10.1017\/S0033291717000046,\u00a0(Epub ahead of print) .","DOI":"10.1017\/S0033291717000046"},{"key":"10.1016\/j.psychres.2017.05.009_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: a Systematic Review","volume":"4","author":"Garc\u00eda","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.05.009_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/NMD.0b013e31819251d8","article-title":"Developing a risk-model of time to first-relapse for children and adolescents with a psychotic disorder","volume":"1","author":"Gearing","year":"2009","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2017.05.009_bib28","doi-asserted-by":"crossref","first-page":"e0123707","DOI":"10.1371\/journal.pone.0123707","article-title":"Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis","volume":"4","author":"Gonz\u00e1lez-Ortega","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2017.05.009_bib29","doi-asserted-by":"crossref","first-page":"e0160949","DOI":"10.1371\/journal.pone.0160949","article-title":"Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History","volume":"8","author":"Gonz\u00e1lez-Pinto","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2017.05.009_bib30","doi-asserted-by":"crossref","DOI":"10.1176\/ps.2010.61.2.189","article-title":"Nonadherence to medication four years after a first episode of psychosis and associated risk factors","author":"Hill","year":"2010","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2017.05.009_bib31","article-title":"Prevention of relapse in chronic schizophrenic patients","author":"Hogarty","year":"1993","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib32","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/0004867413487229","article-title":"A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong","volume":"8","author":"Hui","year":"2013","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0447.2012.01911.x","article-title":"Predictors of medication adherence in patients with schizophrenia and bipolar disorder","volume":"1","author":"Jonsdottir","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.05.009_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/JCP.0b013e3181d2191e","article-title":"Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level","volume":"2","author":"J\u00f3nsd\u00f3ttir","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.05.009_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eurpsy.2005.05.015","article-title":"A prospective evaluation of adherence to medication in first episode schizophrenia","volume":"1","author":"Kamali","year":"2006","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-1781(02)00030-6","article-title":"Indicators of medication compliance in first-episode psychosis","volume":"1","author":"Kampman","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JCP.0b013e3181f058a0","article-title":"Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis","volume":"5","author":"Lambert","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.05.009_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.comppsych.2013.08.018","article-title":"One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?","volume":"2","author":"Lange","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib39","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"9831","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2017.05.009_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/070674371205700204","article-title":"Medication-adherent first-episode psychosis patients also relapse: why?","volume":"2","author":"Levy","year":"2012","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpsyc.1991.01810320088015","article-title":"A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system","volume":"8","author":"McGuffin","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2009.04.018","article-title":"A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia","volume":"2","author":"Miller","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib43","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.53.3.337","article-title":"Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996","author":"Mojtabai","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2017.05.009_bib44","first-page":"1","article-title":"Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia","volume":"1","author":"Morken","year":"2008","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/schbul\/16.1.31","article-title":"Prevalence of substance abuse in schizophrenia","volume":"1","author":"Mueser","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.05.009_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.0001-690X.2003.00193.x","article-title":"Clinical correlates of early medication adherence: west London first episode schizophrenia study","volume":"6","author":"Mutsatsa","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.05.009_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1017\/S0033291703008328","article-title":"How often do patients with psychosis fail to adhere to treatment programmes? A systematic review","volume":"07","author":"Nose","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2017.05.009_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","article-title":"Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia","volume":"2","author":"Novick","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12325-013-0016-5","article-title":"Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia","volume":"3","author":"Offord","year":"2013","journal-title":"Adv. Ther."},{"key":"10.1016\/j.psychres.2017.05.009_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-859X-12-32","article-title":"Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review","volume":"1","author":"Olivares","year":"2013","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib51","first-page":"1","volume":"2011","author":"ONS","year":"2012","journal-title":"Ethn. Natl. Identit-. Engl. Wales"},{"key":"10.1016\/j.psychres.2017.05.009_bib52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1345\/aph.1C321","article-title":"Role of ethnicity in predicting antipsychotic medication adherence","volume":"5","author":"Opolka","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.psychres.2017.05.009_bib53","doi-asserted-by":"crossref","first-page":"e009888","DOI":"10.1136\/bmjopen-2015-009888","article-title":"Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study","volume":"3","author":"Patel","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2017.05.009_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2005.10.016","article-title":"Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode","volume":"1","author":"Perkins","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib55","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/cap.2005.15.901","article-title":"Rates and Predictors of adherence with atypical Antipsychotic medication: AFollow-Up study of adolescent inpatients","volume":"6","author":"Pogge","year":"2005","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.05.009_bib56","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.55.2.174","article-title":"Medication adherence among psychotic patients before admission to inpatient treatment","author":"Rittmannsberger","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2017.05.009_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.eurpsy.2011.03.001","article-title":"Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis","volume":"6","author":"Schimmelmann","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2007.06.004","article-title":"Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients","volume":"1","author":"Schimmelmann","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib59","first-page":"11","article-title":"The effect of cannabis use on memory function: an update","author":"Schoeler","year":"2013","journal-title":"Subst. Abus. Rehabil."},{"key":"10.1016\/j.psychres.2017.05.009_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291715001646","article-title":"The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis","volume":"01","author":"Schoeler","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2017.05.009_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","article-title":"Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib62","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2215-0366(16)30188-2","article-title":"Effects of continuation, frequency and type of cannabis use on relapse in the first two years following onset of psychosis - an observational study","volume":"10","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib63","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2016.2427","article-title":"Examining the association between continued cannabis use and risk of relapse in first episode psychosis: a quasi-experimental investigation within an observational study","volume":"11","author":"Schoeler","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psychres.2014.11.002","article-title":"A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders","volume":"1\u20132","author":"Sendt","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.05.009_bib65","article-title":"Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use","author":"Sideli","year":"2015","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.psychres.2017.05.009_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0920-9964(99)00088-2","article-title":"Reliability of the Life Chart Schedule for assessment of the long-term course of schizophrenia","volume":"1","author":"Susser","year":"2000","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.psychres.2017.05.009_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00406-005-0598-2","article-title":"One year outcome in first episode schizophrenia","volume":"1","author":"\u00dc\u00e7ok","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2017.05.009_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00127-004-0713-0","article-title":"Substance misuse at presentation to an early psychosis program","volume":"1","author":"Van Mastrigt","year":"2004","journal-title":"Social. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psychres.2017.05.009_bib69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-0447.2000.102003203.x","article-title":"Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects","volume":"3","author":"Verdoux","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.05.009_bib70","unstructured":"WHO, 1992. Life Chart Schedule, Geneva, Switzerland."},{"key":"10.1016\/j.psychres.2017.05.009_bib71","series-title":"International Statistical Classification of Diseases and ReLATED HEALTH PROBlems","author":"WHO","year":"2004"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117300550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117300550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T20:50:03Z","timestamp":1535835003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178117300550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":71,"alternative-id":["S0165178117300550"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.05.009","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}